11/5
12:51 pm
srpt
Rating for SRPT
Medium
Report
Rating for SRPT
11/5
12:51 pm
srpt
Rating for SRPT
Medium
Report
Rating for SRPT
11/5
10:27 am
srpt
Rating for SRPT
Low
Report
Rating for SRPT
11/5
10:27 am
srpt
Rating for SRPT
Low
Report
Rating for SRPT
11/5
10:16 am
srpt
Rating for SRPT
Medium
Report
Rating for SRPT
11/5
10:16 am
srpt
Rating for SRPT
Medium
Report
Rating for SRPT
11/5
08:04 am
srpt
Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $26.00 price target on the stock.
High
Report
Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $26.00 price target on the stock.
11/5
08:04 am
srpt
Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $26.00 price target on the stock.
High
Report
Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $26.00 price target on the stock.
11/5
06:01 am
srpt
Rating for SRPT
High
Report
Rating for SRPT
11/5
06:01 am
srpt
Rating for SRPT
High
Report
Rating for SRPT
11/5
04:43 am
srpt
Sarepta upgraded to Outperform from Neutral at Mizuho
High
Report
Sarepta upgraded to Outperform from Neutral at Mizuho
11/5
04:43 am
srpt
Sarepta upgraded to Outperform from Neutral at Mizuho
High
Report
Sarepta upgraded to Outperform from Neutral at Mizuho
11/4
12:21 pm
srpt
Rating for SRPT
Low
Report
Rating for SRPT
11/4
12:21 pm
srpt
Rating for SRPT
Low
Report
Rating for SRPT
9/22
08:08 am
srpt
Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $50.00 price target on the stock.
Low
Report
Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $50.00 price target on the stock.
9/22
07:19 am
srpt
Rating for SRPT
Low
Report
Rating for SRPT
9/22
07:19 am
srpt
Rating for SRPT
Low
Report
Rating for SRPT
9/22
05:09 am
srpt
Sarepta upgraded to Outperform from Market Perform at BMO Capital
Low
Report
Sarepta upgraded to Outperform from Market Perform at BMO Capital
9/22
05:09 am
srpt
Sarepta upgraded to Outperform from Market Perform at BMO Capital
Low
Report
Sarepta upgraded to Outperform from Market Perform at BMO Capital
9/15
08:47 am
srpt
Sarepta Therapeutics (NASDAQ:SRPT) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $22.00 price target on the stock.
Low
Report
Sarepta Therapeutics (NASDAQ:SRPT) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $22.00 price target on the stock.
9/15
08:47 am
srpt
Sarepta Therapeutics (NASDAQ:SRPT) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $22.00 price target on the stock.
Low
Report
Sarepta Therapeutics (NASDAQ:SRPT) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $22.00 price target on the stock.
9/15
08:41 am
srpt
Rating for SRPT
Low
Report
Rating for SRPT
9/15
08:41 am
srpt
Rating for SRPT
Low
Report
Rating for SRPT
9/9
10:00 am
srpt
Rating for SRPT
Low
Report
Rating for SRPT